aser Acupuncture to Temporomandibular Disorder Treatment

Phase 3

• Conditions: Temporomandibular disorders, stress.; C05.500.607.221.897; F01.145.126.990

• Registration Number: RBR-7sw5hf
• Lead Sponsor: uciano Ambrosio Ferreira

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-02
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

All subjects participated in this study volunteers by signing the consent. Female subjects. Aged between 20 and 40. Irrespective of race, creed or social level. Presence of a diagnosis of myofascial pain and arthralgia orofacial chronic, persisting for a minimum period of six months. Minimum intensity of muscle and joint pain of 4.0 points, measured in the Visual Analog Scale (VAS) during the first evaluation.

Exclusion Criteria

Subjects with evidence of muscle diseases, rheumatic and joint systemic origin, such as fibromyalgia and rheumatoid arthritis. Presence of fungal skin changes, hyperplastic, erythematous keloid or continuity in areas related to acupuncture points. Medical, pharmacological, psychological or physical therapy for temporomandibular disorder (TMD), concomitant therapies introduced in this study. Pregnants, the possible influence of intrauterine contraction and movement promoted by some acupuncture points such as LI4. Report or finding of facial trauma as a possible etiology of temporomandibular disorder. Individuals who have undergone prior treatment with neuromuscular relaxing plate, acupuncture or laser therapy for temporomandibular disorder. Subject denture wearers an upper or lower. Individuals with intellectual disability or impairment that would hinder the collection of data.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Physical symptoms evaluation before the intervention and after 1, 2 and 3 months after the intervention. Measurement of muscle and joint pain orofacial by applying the visual analogue scale to palpation stomatognathic sites . At each time, the average intensity of pain experienced by each group will be mensured. The provision of these temporal averages (moments of 0, 1, 2 and 3) will prepare the development of physical symptoms in each group. This evolution will be compared between the groups in order to verify the effectiveness of proposed therapies.

Secondary Outcome Measures

Name	Time	Method
Diagnostic Criteria for Temporomandibular Disorders Research (RDC / TMD, Axis II) to assess the psychosocial impact of emotional distress associated to temporomandibular disorder. Levels of depression and no specific sumptoms (somatization) will be measured through SCL 90R questionary, contained in RDC/DTM. This instrument will be applied before and after institution of therapy in each group. A comparison of symptoms of somatization and depression in the two instances indicate a possible change of these symptoms.